Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Barmaz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Drug Safety|July 14, 2021
Bayesian Modeling for the Detection of Adverse Events Underreporting in Clinical TrialsYves Barmaz, Timothé Ménard
Drug Safety|May 25, 2019
Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine LearningTimothé Ménard, Yves Barmaz, Björn Koneswarakantha, et al.
Therapeutic Innovation & Regulatory Science|September 1, 2020
Harnessing the Power of Quality Assurance Data: Can We Use Statistical Modeling for Quality Risk Assessment of Clinical Trials?Björn Koneswarakantha, Timothé Ménard, Donato Rolo, et al.
Therapeutic Innovation & Regulatory Science|August 18, 2020
Using Statistical Modeling for Enhanced and Flexible Pharmacovigilance Audit Risk Assessment and PlanningMin Zou, Yves Barmaz, Melissa Preovolos, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Drug Safety|July 14, 2021
Bayesian Modeling for the Detection of Adverse Events Underreporting in Clinical TrialsYves Barmaz, Timothé Ménard
Drug Safety|May 25, 2019
Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine LearningTimothé Ménard, Yves Barmaz, Björn Koneswarakantha, et al.
Therapeutic Innovation & Regulatory Science|September 1, 2020
Harnessing the Power of Quality Assurance Data: Can We Use Statistical Modeling for Quality Risk Assessment of Clinical Trials?Björn Koneswarakantha, Timothé Ménard, Donato Rolo, et al.
Therapeutic Innovation & Regulatory Science|August 18, 2020
Using Statistical Modeling for Enhanced and Flexible Pharmacovigilance Audit Risk Assessment and PlanningMin Zou, Yves Barmaz, Melissa Preovolos, et al.
Pageof 1